Arc Secures $10.8M Seed

Trellis Bioscience Inc.

Trellis Bioscience is a clinical-stage company focused on discovering and developing native human monoclonal antibodies to treat and prevent drug-resistant, life-threatening infectious diseases. Antibodies are the immune system's most potent natural weapon against disease. Trellis's innovative proprietary technology CellSpot™ overcomes technical obstacles that have long hindered exploiting the full human antibody repertoire. This ideal source of drugs focuses on the selection of elite antibodies that bind highly conserved target epitopes with high affinity. TRL1068 is a native human monoclonal antibody (for intravenous delivery) whose target is a family of bacterial proteins (DNABII) that play a critical role in maintaining the structural integrity of biofilms by anchoring extracellular bacterial DNA (eDNA) from dead bacteria within the biofilm matrix. TRL1068 binds at high affinity (Kd ~50 pM) to a highly conserved epitope found in nearly all medically significant bacteria, including both Gram-positive and Gram-negative species. High affinity binding to DNABII ensures that the protein is eliminated from the body and thus prevents its deposition elsewhere in the body, where it could form biofilm metastases. Because the bacterial target is only exposed to the antibody after the producing bacterial cell is dead, resistance to this novel intervention is expected to be rare. The FDA granted Fast Track, QIDP (qualified infectious disease product), and Orphan Drug designations for TRL1068.

P2 Science, Inc.

We are the New Green Chemistry Company with a mission to de-carbonize the chemical industry, using the power of green chemistry.

Riboscience

Riboscience is a clinical stage biotechnology company developing treatments for serious infectious diseases and cancer. We apply ribose and structure-guided design technologies to the discovery of drugs that target proteins that are essential and unique to specific infectious pathogens, tumor cells or the anti-tumor immune response.

Lokam.ai

Lokam.ai integrates with your DMS and CRM collects honest feedback from your customers after every service and showroom visits through conversations, not surveys. When a service customer is frustrated, we flag it before they silently churn saving thousands dollars in lifetime value. When a showroom visitor walks away without buying a new car, we find out exactly why and escalate to the sales team immediately. Instead of ignored text surveys, Lokam’s empathetic voice AI calls every customer and truly listen to their concerns. Our AI-Powered analysis aggregates every call, trend, and advisor metric, giving leaders the clarity to fix issues fast and double-down on what works.

Flexprice

Open source metering & billing built for developers Build usage-based, credit-based, or hybrid pricing models with ease. Flexprice handles metering, pricing, and invoicing so you can focus on building, not billing. With Flexprice, move from "We need a dev sprint” to "We can support it today" - Deploy on cloud or self-host — your infra, your choice - No-code UI to let business teams run pricing without developer help - Say goodbye to spending countless hours on pricing changes - Track LLM and GPU costs in real time to protect your margins ? Explore: https://github.com/flexprice/flexprice/